ACRS Insider Trading

Insider Ownership Percentage: 5.50%
Insider Buying (Last 12 Months): $99,994.00
Insider Selling (Last 12 Months): $136,080.00

Aclaris Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aclaris Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aclaris Therapeutics Share Price & Price History

Current Price: $1.18
Price Change: Price Increase of +0.03 (2.61%)
As of 05/23/2024 01:00 AM ET

This chart shows the closing price history over time for ACRS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aclaris Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/23/2023Joseph MonahanInsiderSell6,000$5.08$30,480.00129,724View SEC Filing Icon  
8/28/2023James LoeropInsiderBuy14,705$6.80$99,994.0021,688View SEC Filing Icon  
8/21/2023Joseph MonahanInsiderSell6,000$7.32$43,920.00135,724View SEC Filing Icon  
6/20/2023Joseph MonahanInsiderSell6,000$10.28$61,680.00141,724View SEC Filing Icon  
3/9/2023Douglas J ManionCEOBuy6,500$7.74$50,310.006,500View SEC Filing Icon  
3/2/2023Joseph MonahanInsiderSell14,800$12.37$183,076.00151,261View SEC Filing Icon  
3/2/2023Kevin BalthaserCFOSell1,000$12.29$12,290.004,650View SEC Filing Icon  
3/2/2023Neal WalkerDirectorSell29,000$12.37$358,730.001,285,188View SEC Filing Icon  
2/8/2023James LoeropInsiderSell4,267$13.89$59,268.636,983View SEC Filing Icon  
1/3/2023Neal WalkerDirectorSell25,000$15.25$381,250.001,220,763View SEC Filing Icon  
12/15/2022Joseph MonahanInsiderSell5,000$15.88$79,400.0096,386View SEC Filing Icon  
10/26/2022Andrew N SchiffDirectorSell14,540$17.00$247,180.00488,381View SEC Filing Icon  
10/24/2022Andrew N SchiffDirectorSell14,616$17.01$248,618.16514,939View SEC Filing Icon  
10/17/2022Andrew N SchiffDirectorSell19,944$16.05$320,101.20561,648View SEC Filing Icon  
10/17/2022Joseph MonahanInsiderSell5,000$15.98$79,900.00101,386View SEC Filing Icon  
10/6/2022Andrew N SchiffDirectorSell37,839$16.54$625,857.06588,916View SEC Filing Icon  
10/4/2022Andrew N SchiffDirectorSell7,700$16.01$123,277.00626,755View SEC Filing Icon  
6/17/2022Andrew N. SchiffDirectorSell19,565$15.14$296,214.10View SEC Filing Icon  
4/25/2022Neal WalkerCEOSell20,000$15.18$303,600.001,245,763View SEC Filing Icon  
4/21/2022Neal WalkerCEOSell25,000$15.24$381,000.001,290,763View SEC Filing Icon  
4/18/2022Joseph MonahanInsiderSell30,000$16.28$488,400.00106,386View SEC Filing Icon  
3/11/2022Neal WalkerCEOSell56,303$15.91$895,780.73View SEC Filing Icon  
3/10/2022Frank RuffoCFOSell12,823$15.55$199,397.65View SEC Filing Icon  
3/10/2022Joseph MonahanInsiderSell27,165$15.71$426,762.15View SEC Filing Icon  
2/9/2022Joseph MonahanInsiderSell383$12.68$4,856.44View SEC Filing Icon  
7/13/2021David N. GordonInsiderSell2,631$16.98$44,674.38147,447View SEC Filing Icon  
6/3/2021Kamil Ali-JacksonInsiderSell9,492$21.96$208,444.32122,196View SEC Filing Icon  
6/2/2021Neal WalkerCEOSell33,260$21.64$719,746.401,265,442View SEC Filing Icon  
6/1/2021David N. GordonInsiderSell14,000$23.01$322,140.00195,992View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

98.34% of Aclaris Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACRS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aclaris Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2024Bain Capital Life Sciences Investors LLC3,000,000$3.72M0.3%-14.3%4.210%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC2,135,367$2.65M0.0%-9.2%2.996%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.4,929,775$6.11M0.0%+4.4%6.918%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.62,772$78K0.0%+5,265.1%0.088%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC32,843$41K0.0%+69.5%0.046%Search for SEC Filing on Google Icon
5/7/2024Marquette Asset Management LLC83,979$0.10M0.0%N/A0.118%Search for SEC Filing on Google Icon
5/7/2024Deuterium Capital Management LLC79,993$99K0.2%N/A0.112%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP679,137$0.84M0.1%-57.2%0.953%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets241,101$0.30M0.0%+10.9%0.338%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.31,552$39K0.0%N/A0.044%Search for SEC Filing on Google Icon
4/23/2024BML Capital Management LLC9,395,934$11.65M7.7%+1,338.7%13.248%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP100,000$0.11M0.0%N/A0.141%Search for SEC Filing on Google Icon
2/13/2024Bain Capital Life Sciences Investors LLC3,500,000$3.68M0.4%+2.9%4.944%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM979,399$1.03M0.3%N/A1.384%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank43,784$46K0.0%+115.5%0.062%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC653,107$0.69M0.5%N/A0.923%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio193,000$0.20M0.0%+256.7%0.273%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.30,268$32K0.0%+128.8%0.043%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.3,363,046$23.04M0.0%+1.0%4.751%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.11,864$81K0.0%-60.6%0.017%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP6,979,844$47.81M0.0%-8.6%9.860%Search for SEC Filing on Google Icon
11/14/2023Blackstone Inc.1,261,425$8.64M0.0%+9,578.7%1.782%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC269,746$1.85M0.0%-40.6%0.381%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.14,916$0.10M0.1%N/A0.021%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP127,851$0.88M0.0%N/A0.181%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC45,120$0.31M0.0%N/A0.064%Search for SEC Filing on Google Icon
11/13/2023FMR LLC661,300$4.53M0.0%-11.6%0.934%Search for SEC Filing on Google Icon
11/13/2023Lord Abbett & CO. LLC453,954$3.11M0.0%+14.0%0.641%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG154,309$1.06M0.0%-85.8%0.218%Search for SEC Filing on Google Icon
11/8/2023HighTower Advisors LLC369,802$2.53M0.0%-2.6%0.522%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC234,150$1.60M0.0%+174.2%0.331%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.687,135$4.71M0.0%+7.9%0.971%Search for SEC Filing on Google Icon
10/25/2023Zurcher Kantonalbank Zurich Cantonalbank20,317$0.14M0.0%+42.6%0.029%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC151,704$1.04M0.0%+20.1%0.214%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC85,389$0.89M0.0%-54.7%0.121%Search for SEC Filing on Google Icon
8/15/2023HighVista Strategies LLC86,103$0.89M0.4%-56.5%0.122%Search for SEC Filing on Google Icon
8/15/2023Braidwell LP2,901,194$30.09M1.0%-11.3%4.098%Search for SEC Filing on Google Icon
8/11/2023Westwood Holdings Group Inc.51,023$0.53M0.0%N/A0.072%Search for SEC Filing on Google Icon
8/11/2023Hsbc Holdings PLC249,842$2.61M0.0%N/A0.353%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.19,133$0.20M0.0%+13.0%0.027%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.33,429$0.35M0.0%+7.2%0.047%Search for SEC Filing on Google Icon
8/3/2023Los Angeles Capital Management LLC75,006$0.78M0.0%N/A0.106%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC85,389$0.89M0.0%-54.7%0.121%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp242,426$2.51M0.0%+5.3%0.343%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio54,100$0.56M0.0%+8.4%0.077%Search for SEC Filing on Google Icon
7/25/2023Assenagon Asset Management S.A.636,829$6.60M0.0%+49.6%0.901%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC126,347$1.31M0.0%+323.4%0.179%Search for SEC Filing on Google Icon
5/16/2023BVF Inc. IL3,360,941$27.19M1.0%+2.6%4.755%Search for SEC Filing on Google Icon
5/16/2023Bain Capital Life Sciences Investors LLC3,400,000$27.51M3.4%N/A4.810%Search for SEC Filing on Google Icon
5/15/2023Commodore Capital LP635,000$5.14M0.8%-66.2%0.898%Search for SEC Filing on Google Icon
5/15/2023Ghost Tree Capital LLC425,000$3.44M1.0%N/A0.601%Search for SEC Filing on Google Icon
5/12/2023Wellington Management Group LLP7,372,601$59.64M0.0%+34.4%10.431%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.176,650$1.43M0.0%+948.6%0.250%Search for SEC Filing on Google Icon
5/10/2023Ovata Capital Management Ltd15,000$0.12M0.1%N/A0.021%Search for SEC Filing on Google Icon
5/2/2023Amalgamated Bank9,098$74K0.0%-13.0%0.013%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC29,843$0.24M0.0%+305.4%0.042%Search for SEC Filing on Google Icon
4/27/2023Strs Ohio49,900$0.40M0.0%+37.1%0.071%Search for SEC Filing on Google Icon
4/18/2023Assenagon Asset Management S.A.425,828$3.45M0.0%+118.5%0.639%Search for SEC Filing on Google Icon
4/12/2023Vontobel Holding Ltd.14,228$0.12M0.0%N/A0.021%Search for SEC Filing on Google Icon
3/23/2023MetLife Investment Management LLC33,899$0.53M0.0%+8.4%0.051%Search for SEC Filing on Google Icon
2/22/2023Teachers Retirement System of The State of Kentucky57,009$0.90M0.0%+5.6%0.085%Search for SEC Filing on Google Icon
2/15/2023Braidwell LP2,393,985$37.71M1.3%N/A3.590%Search for SEC Filing on Google Icon
2/14/2023Verition Fund Management LLC405,568$6.39M0.1%+8.9%0.608%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC1,121,752$17.67M0.0%-5.4%1.682%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.16,846$0.27M0.0%-37.3%0.025%Search for SEC Filing on Google Icon
2/10/2023HRT Financial LP45,535$0.72M0.0%N/A0.068%Search for SEC Filing on Google Icon
2/10/2023Cheyne Capital Management UK LLP50,964$0.80M1.4%N/A0.076%Search for SEC Filing on Google Icon
2/9/2023Mirae Asset Global Investments Co. Ltd.31,135$0.49M0.0%+16.6%0.047%Search for SEC Filing on Google Icon
2/9/2023Aisling Capital Management LP434,455$6.84M4.5%-31.5%0.652%Search for SEC Filing on Google Icon
2/9/2023Principal Financial Group Inc.18,208$0.29M0.0%+11.0%0.027%Search for SEC Filing on Google Icon
2/9/2023HighTower Advisors LLC192,424$3.03M0.0%+229.8%0.289%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank112,600$1.77M0.0%+1.9%0.169%Search for SEC Filing on Google Icon
2/7/2023Fox Run Management L.L.C.16,350$0.26M0.1%+9.5%0.025%Search for SEC Filing on Google Icon
2/7/2023Handelsbanken Fonder AB14,800$0.23M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/3/2023Frazier Life Sciences Management L.P.290,189$4.57M0.3%-28.9%0.435%Search for SEC Filing on Google Icon
2/2/2023SG Americas Securities LLC7,361$0.12M0.0%-45.9%0.011%Search for SEC Filing on Google Icon
2/2/2023ProShare Advisors LLC13,828$0.22M0.0%+8.6%0.021%Search for SEC Filing on Google Icon
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank9,759$0.15M0.0%+30.1%0.015%Search for SEC Filing on Google Icon
1/26/2023Strs Ohio36,400$0.57M0.0%+82.9%0.055%Search for SEC Filing on Google Icon
1/23/2023Allspring Global Investments Holdings LLC65,307$1.03M0.0%-1.3%0.098%Search for SEC Filing on Google Icon
11/15/2022Parkman Healthcare Partners LLC233,626$3.68M1.0%-23.4%0.350%Search for SEC Filing on Google Icon
11/15/2022Laurion Capital Management LP1,304,624$20.54M0.1%-9.4%1.957%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC1,118,417$17.60M0.0%+17.3%1.677%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.1,853,251$29.17M0.1%+6.9%2.779%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC1,185,178$18.66M0.0%-10.9%1.777%Search for SEC Filing on Google Icon
11/14/2022Verition Fund Management LLC372,507$5.86M0.1%+11.3%0.559%Search for SEC Filing on Google Icon
11/14/2022AXA S.A.18,200$0.29M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/14/2022Integral Health Asset Management LLC340,000$5.35M1.0%+18.9%0.510%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.26,854$0.42M0.0%N/A0.040%Search for SEC Filing on Google Icon
11/9/2022Amalgamated Bank10,453$0.17M0.0%+10.6%0.016%Search for SEC Filing on Google Icon
11/8/2022Allianz Asset Management GmbH21,800$0.34M0.0%-78.2%0.033%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund46,808$0.74M0.0%+20.5%0.070%Search for SEC Filing on Google Icon
11/7/2022Fox Run Management L.L.C.14,928$0.24M0.1%N/A0.022%Search for SEC Filing on Google Icon
11/7/2022Arizona State Retirement System12,665$0.20M0.0%+9.0%0.019%Search for SEC Filing on Google Icon
11/7/2022ProShare Advisors LLC12,730$0.20M0.0%+6.9%0.019%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC16,707$0.26M0.0%-24.0%0.025%Search for SEC Filing on Google Icon
11/1/2022Great West Life Assurance Co. Can1,944$31K0.0%N/A0.003%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC13,598$0.21M0.0%N/A0.020%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC543,776$8.56M2.9%+0.8%0.816%Search for SEC Filing on Google Icon
10/27/2022Assenagon Asset Management S.A.194,923$3.07M0.0%-33.5%0.292%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aclaris Therapeutics logo
Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment provides laboratory services. It develops Zunsemetinib (ATI-450), an MK2 inhibitor which is under Phase 1b/2 trials for the treatment of metastatic breast and pancreatic cancer; ATI-1777, a soft JAK 1/3 inhibitor, completed Phase 2b trails for the treatment of moderate to severe atopic dermatitis and other dermatologic conditions; and ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor under Phase 1 trials as a treatment for T cell-mediated autoimmune diseases. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.
Read More on Aclaris Therapeutics

Today's Range

Now: $1.18
Low: $1.15
High: $1.20

50 Day Range

MA: $1.21
Low: $1.15
High: $1.36

52 Week Range

Now: $1.18
Low: $0.59
High: $11.12

Volume

585,462 shs

Average Volume

1,337,253 shs

Market Capitalization

$84.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.23

Who are the company insiders with the largest holdings of Aclaris Therapeutics?

Aclaris Therapeutics' top insider shareholders include:
  1. Neal Walker (Director)
  2. Andrew N Schiff (Director)
  3. Joseph Monahan (Insider)
  4. James Loerop (Insider)
  5. Douglas J Manion (CEO)
  6. Kevin Balthaser (CFO)
  7. Andrew N Schiff (Director)
Learn More about top insider investors at Aclaris Therapeutics.

Who are the major institutional investors of Aclaris Therapeutics?

Aclaris Therapeutics' top institutional investors include:
  1. BML Capital Management LLC — 13.25%
  2. Vanguard Group Inc. — 6.92%
  3. Bain Capital Life Sciences Investors LLC — 4.21%
  4. Acadian Asset Management LLC — 3.00%
  5. GSA Capital Partners LLP — 0.95%
  6. BNP Paribas Financial Markets — 0.34%
Learn More about top institutional investors of Aclaris Therapeutics stock.

Which major investors are selling Aclaris Therapeutics stock?

Within the last quarter, ACRS stock was sold by these institutional investors:
  1. GSA Capital Partners LLP
  2. Bain Capital Life Sciences Investors LLC
  3. Acadian Asset Management LLC

Which major investors are buying Aclaris Therapeutics stock?

During the previous quarter, ACRS stock was purchased by institutional investors including:
  1. BML Capital Management LLC
  2. Vanguard Group Inc.
  3. Marquette Asset Management LLC
  4. Deuterium Capital Management LLC
  5. Russell Investments Group Ltd.
  6. Mirae Asset Global Investments Co. Ltd.
  7. BNP Paribas Financial Markets
  8. SG Americas Securities LLC
During the previous year, these company insiders have bought Aclaris Therapeutics stock:
  1. Neal Walker (Director)
  2. Andrew N Schiff (Director)
Learn More investors buying Aclaris Therapeutics stock.